Buellesfeld L - Search Results

1

Six-month clinical and angiographic results of a dedicated drug-eluting stent for the treatment of coronary bifurcation narrowings.

Grube E, Buellesfeld L, Neumann FJ, Verheye S, Abizaid A, McClean D, Mueller R, Lansky A, Mehran R, Costa R, Gerckens U, Trauthen B, Fitzgerald PJ. Grube E, et al. Among authors: buellesfeld l. Am J Cardiol. 2007 Jun 15;99(12):1691-7. doi: 10.1016/j.amjcard.2007.01.043. Epub 2007 May 7. Am J Cardiol. 2007. PMID: 17560877

2

Drug-eluting stents: clinical experiences and perspectives.

Grube E, Gerckens U, Buellesfeld L. Grube E, et al. Among authors: buellesfeld l. Minerva Cardioangiol. 2002 Oct;50(5):469-73. Minerva Cardioangiol. 2002. PMID: 12384629 Review.

3

Results of the Jostent coronary stent graft implantation in various clinical settings: procedural and follow-up results.

Gercken U, Lansky AJ, Buellesfeld L, Desai K, Badereldin M, Mueller R, Selbach G, Leon MB, Grube E. Gercken U, et al. Among authors: buellesfeld l. Catheter Cardiovasc Interv. 2002 Jul;56(3):353-60. doi: 10.1002/ccd.10223. Catheter Cardiovasc Interv. 2002. PMID: 12112888

4

TAXUS I: six- and twelve-month results from a randomized, double-blind trial on a slow-release paclitaxel-eluting stent for de novo coronary lesions.

Grube E, Silber S, Hauptmann KE, Mueller R, Buellesfeld L, Gerckens U, Russell ME. Grube E, et al. Among authors: buellesfeld l. Circulation. 2003 Jan 7;107(1):38-42. doi: 10.1161/01.cir.0000047700.58683.a1. Circulation. 2003. PMID: 12515740 Clinical Trial.

5

Rapamycin analogs for stent-based local drug delivery. Everolimus- and tacrolimus-eluting stents.

Grube E, Buellesfeld L. Grube E, et al. Among authors: buellesfeld l. Herz. 2004 Mar;29(2):162-6. doi: 10.1007/s00059-004-2556-6. Herz. 2004. PMID: 15054588 Review.

6

ABT-578-eluting stents. The promising successor of sirolimus- and paclitaxel-eluting stent concepts?

Buellesfeld L, Grube E. Buellesfeld L, et al. Herz. 2004 Mar;29(2):167-70. doi: 10.1007/s00059-004-2557-5. Herz. 2004. PMID: 15054589 Review.

7

Everolimus for stent-based intracoronary applications.

Grube E, Buellesfeld L. Grube E, et al. Among authors: buellesfeld l. Rev Cardiovasc Med. 2004;5 Suppl 2:S3-8. Rev Cardiovasc Med. 2004. PMID: 15184828

8

Paclitaxel-eluting stents: current clinical experience.

Grube E, Buellesfeld L. Grube E, et al. Among authors: buellesfeld l. Am J Cardiovasc Drugs. 2004;4(6):355-60. doi: 10.2165/00129784-200404060-00003. Am J Cardiovasc Drugs. 2004. PMID: 15554720 Review.

9

Two-year-plus follow-up of a paclitaxel-eluting stent in de novo coronary narrowings (TAXUS I).

Grube E, Silber S, Hauptmann KE, Buellesfeld L, Mueller R, Lim V, Gerckens U, Russell ME. Grube E, et al. Among authors: buellesfeld l. Am J Cardiol. 2005 Jul 1;96(1):79-82. doi: 10.1016/j.amjcard.2005.03.030. Am J Cardiol. 2005. PMID: 15979439 Clinical Trial.

10

Polymer-based paclitaxel-eluting stent for treatment of chronic total occlusions of native coronaries: results of a Taxus CTO registry.

Buellesfeld L, Gerckens U, Mueller R, Schmidt T, Grube E. Buellesfeld L, et al. Catheter Cardiovasc Interv. 2005 Oct;66(2):173-7. doi: 10.1002/ccd.20477. Catheter Cardiovasc Interv. 2005. PMID: 16144017

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

86 results

Search Page

Filters